Signals Group Joins the Coalition for Kidney Health

The media and research firm will contribute to the coalition's efforts to drive earlier detection and coordinated care for chronic kidney disease.

Apr. 2, 2026 at 8:37pm

Got story updates? Submit your updates here. ›

A ghostly, translucent X-ray photograph of a human kidney, revealing its intricate internal structures in a glowing, ethereal way against a dark background, conceptually representing the complex challenges of chronic kidney disease.A translucent X-ray image of a human kidney highlights the complex internal structures that are the focus of the Coalition for Kidney Health's efforts to improve early detection and management of chronic kidney disease.San Diego Today

Signals Group, a media and research firm focused on kidney health, innovation, and policy, has announced its membership in the Coalition for Kidney Health (C4KH). The C4KH is a multistakeholder initiative convened by the National Kidney Foundation to advance early detection and management of chronic kidney disease (CKD). Signals Group's work, spanning original research, editorial coverage, and engagement with innovators across kidney and cardiometabolic health, is aligned with the coalition's goals of shifting the paradigm from reactive treatment of kidney failure to proactive prevention, screening, and coordinated care.

Why it matters

Chronic kidney disease is deeply intertwined with diabetes, hypertension, and cardiovascular disease, affecting nearly 90% of U.S. adults. However, 37 million people living with CKD remain undiagnosed. The Coalition for Kidney Health aims to address this gap by bringing together clinicians, patients, policymakers, and innovators to drive earlier detection and more coordinated care. Signals Group's membership and contributions can help amplify these goals and accelerate stakeholder alignment.

The details

The Coalition for Kidney Health is working to shift the paradigm from reactive treatment of kidney failure to proactive prevention, screening, and coordinated care across the continuum. Recent actions include a white paper calling on the Centers for Medicare and Medicaid Innovation (CMMI) to embed early CKD detection into its value-based care portfolio, and a letter to CMMI urging the inclusion of guideline-concordant kidney disease screening in the upcoming ACCESS Model. Signals Group's work, spanning original research, editorial coverage, and engagement with innovators across kidney and cardiometabolic health, is uniquely positioned to contribute to these efforts.

  • The Coalition for Kidney Health enters 2026 with an ambitious agenda.
  • Last fall, Signals convened members of the Coalition to share their white paper and policy priorities.

The players

Signals Group

A media and research firm operating at the intersection of kidney health, innovation, and policy.

Coalition for Kidney Health (C4KH)

A multistakeholder initiative convened by the National Kidney Foundation to advance early detection and management of chronic kidney disease.

National Kidney Foundation (NKF)

The organization that convened the Coalition for Kidney Health.

Miriam Godwin

Vice President of Health Policy at the National Kidney Foundation.

Tim Fitzpatrick

Founder of Signals Group.

Got photos? Submit your photos here. ›

What they’re saying

“In the United States, 37 million people are living with chronic kidney disease, yet most remain undiagnosed. Addressing this gap requires better alignment across clinicians, patients, policymakers, and innovators. The Coalition for Kidney Health is bringing those voices together to drive earlier detection and more coordinated care, and partners like Signals Group play an important role in translating complex science and policy into insights that can improve care at scale.”

— Miriam Godwin, Vice President of Health Policy at the National Kidney Foundation

“We built Signals Group around a simple conviction: that kidney disease does not get the attention it deserves, and that closing that gap requires better communication across every part of the ecosystem. The Coalition is shaping what the next decade of CKM care looks like. We're proud to be part of that work.”

— Tim Fitzpatrick, Founder of Signals Group

What’s next

The Coalition for Kidney Health enters 2026 with an ambitious agenda, including securing a USPSTF screening recommendation for CKD, expanding the Kidney Health Evaluation for Patients With Diabetes (KED) measure to include patients with hypertension, advancing a next-generation kidney care model within CMMI's specialty care strategy, and pressing for policy changes that expand access to Medical Nutrition Therapy and Kidney Disease Education.

The takeaway

Signals Group's membership in the Coalition for Kidney Health underscores the urgent need to address the gap in chronic kidney disease detection and management. By contributing its expertise in research, editorial coverage, and stakeholder engagement, Signals can help drive the coalition's efforts to shift the paradigm from reactive treatment to proactive prevention and coordinated care.